ADVANCEMENT OF A NOVEL THERAPEUTIC STRATEGY FOR THERAPEUTIC DEVELOPMENT IN ALS: TARGETING THE RAGE/DIAPH1 AXIS
$2,536,839FY2025Defense Health AgencyDOD
New York University, New York NY
Investigators
View source on USAspending →ADVANCEMENT OF A NOVEL THERAPEUTIC STRATEGY FOR THERAPEUTIC DEVELOPMENT IN ALS: TARGETING THE RAGE/DIAPH1 AXIS · GrantIndex